Contingencies and commitments - Universal Cells Research, Collaboration and License Agreement and Co-development and Co-commercialization agreement (Details) - Collaboration and license agreement - Universal Cells, Inc. - USD ($) |
1 Months Ended | 12 Months Ended | ||||
---|---|---|---|---|---|---|
Nov. 25, 2015 |
Feb. 29, 2016 |
Dec. 31, 2018 |
Dec. 31, 2017 |
Dec. 31, 2023 |
Dec. 31, 2022 |
|
Contingencies and commitments | ||||||
Upfront license and start-up fees | $ 2,500,000 | |||||
Milestone payments | $ 3,000,000 | $ 200,000 | $ 900,000 | |||
First milestone payment | $ 500,000 | |||||
Second milestone payment | 600,000 | |||||
Third milestone payment | $ 400,000 | |||||
Milestone payment accrued but not yet paid | $ 0 |
X | ||||||||||
- Definition The amount of milestone payment accrued but not yet paid. No definition available.
|
X | ||||||||||
- Definition The amount of milestone payment. No definition available.
|
X | ||||||||||
- Definition The amount of milestone payment three. No definition available.
|
X | ||||||||||
- Definition The amount of milestone payment two. No definition available.
|
X | ||||||||||
- Definition Represents the amount of milestone payments made by the entity under the license agreement. No definition available.
|
X | ||||||||||
- Definition Represents the amount of upfront and start-up fees paid. No definition available.
|
X | ||||||||||
- Definition Line items represent financial concepts included in a table. These concepts are used to disclose reportable information associated with domain members defined in one or many axes to the table. Reference 1: http://www.xbrl.org/2003/role/disclosureRef
|
X | ||||||||||
- Details
|
X | ||||||||||
- Details
|